Cite Filings / DMRA / 0001564590-22-000413

Feed Companies Filings Check

Sign in

8-K

Current Report

Damora Therapeutics, Inc. Filed 2022-01-05 Acc 0001564590-22-000413

Regulation FD disclosure

Item 7.01 Regulation FD disclosure

From the SEC's structured data for this filing

Documents 1

8-K Current Report , glto-8k_20220105.htm

Around this filing

2022-01-27 8-K Other events
2022-01-06 4 Options or other derivatives
2022-01-06 4 Options or other derivatives
2022-01-06 4 Options or other derivatives
2022-01-05 8-K Regulation FD disclosure
2022-01-05 3 Initial Statement of Ownership
2021-07-06 8-K Executive or director change

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)
SEC Structured Data (opens in new tab)

Loading glto-8k_20220105.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…